Enovis Corp (LTS:0I1B)
$ 48.35 -0.10705 (-0.22%) Market Cap: 2.73 Bil Enterprise Value: 4.11 Bil PE Ratio: 0 PB Ratio: 0.82 GF Score: 68/100

Enovis Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 11:00PM GMT
Release Date Price: $54.86
Caroline Borowski

Thank you all. My name is Caroline Borowski, and I'm an associate here at the JPMorgan Health Care team. It is my pleasure to introduce Matt Trerotola, the CEO; Ben Berry, the CFO; and Derek Leckow, the Vice President of Investor Relations here at Enovis.

Matthew L. Trerotola
Enovis Corporation - CEO & Director

Great. Thank you. Thank you very much. It's great to be here and have a chance this afternoon to introduce you to our company, Enovis. In some ways, we're a brand-new company as of April 4th of last year, but we've got actually a very rich heritage. We came from a company called Colfax. It was founded by Mitch and Steve Rales, who founded the extremely successful Danaher Corporation. And our med tech businesses have rich and deep heritage within the orthopedics space as well. You can read the forward-looking statement.

I'm going to talk a little bit about our markets and our positions in them and what's great about those positions in the markets, talk about our strategy for how we're going to grow our company high single digits

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot